Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study ; volume:20 ; number:1 ; day:25 ; month:3 ; year:2020 ; pages:1-10 ; date:12.2020
BMC pediatrics ; 20, Heft 1 (25.3.2020), 1-10, 12.2020
- Creator
-
van Katwyk, Sasha
Augustine, Sajit
Thébaud, Bernard
Thavorn, Kednapa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-020-02037-5
- URN
-
urn:nbn:de:101:1-2020061619150919934346
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van Katwyk, Sasha
- Augustine, Sajit
- Thébaud, Bernard
- Thavorn, Kednapa
- SpringerLink (Online service)
Other Objects (12)
Virus infections as risk factors in the development of bronchopulmonary dysplasia (BPD)
Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
Virus infections as risk factors in the development of bronchopulmonary dysplasia (BPD)
Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
Virus infections as risk factors in the development of bronchopulmonary dysplasia (BPD)
Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia